Tag: AstraZeneca
Indian experts panel backs Oxford-AstraZeneca COVID-19 vaccine for emergency use
A subject expert committee of India's Central Drug Standard Control Organisation has recommended 'Covishield', the COVID-19 vaccine co-developed by British pharmaceutical firm AstraZeneca and...
Oxford-AstraZeneca COVID-19 vaccine secures UK approval for use
Britain became the first country in the world to approve the coronavirus vaccine developed by Oxford University and AstraZeneca as the nation battles the...
Oxford vaccine 95% effective if given 2-3 months apart: SII
Oxford University and UK-based AstraZeneca will soon release data showing that if the two shots are separated by around 2-3 months, the efficacy of...
UK-based drugmaker AstraZeneca to acquire Alexion
British pharmaceutical giant behind the most anticipated Oxford COVID-19 vaccine, AstraZeneca has decided to acquire U.S. drugmaker Alexion Pharmaceuticals for $39 billion.
The move, the...
AstraZeneca-Sputnik V COVID-19 vaccines prepare for a combined trial
In collaboration with the Russian Gamaleya Research Institute, the Russian Direct Investment Fund (RDIF) and R-Pharm, UK-based drugmaker AstraZeneca will conduct a clinical trial...
Oxford COVID-19 vaccine faces tough questions after manufacturing error reveal
After acknowledging a manufacturing error, University of Oxford and drugmaker AstraZeneca face mounting questions about their COVID-19 vaccine trial results.
Although an announcement by Oxford...
Oxford’s COVID-19 vaccine gives 70% protection: Trial results up expectations
A large-scale study shows that the coronavirus vaccine developed by the University of Oxford in collaboration with drugmaker AstraZeneca prevents 70 percent of people...
Phase 3 COVID-19 vaccine trial data by Christmas; Oxford researchers
While conversing on the latest results from the ongoing late-stage trials of AstraZeneca-Oxford COVID-19 vaccine candidate, Dr. Andrew Pollard, an expert in pediatric infection...
